BridgeBio Pharma Inc
Ownership
Ownership Structure
Who owns BridgeBio Pharma Inc (BBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.5% of the shares are freely tradable; institutional investors hold 103.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.27 | 14,207,757 | -2.3 | 03/31/2026 |
| Kohlberg Kravis Roberts & Co LP | 6.78 | 13,260,971 | +0.0 | 03/31/2026 |
| HHG PLC | 6.74 | 13,179,013 | +19.8 | 03/31/2026 |
| Viking Global Investors LP | 6.06 | 11,842,434 | -17.7 | 03/31/2026 |
| Farallon Capital Management, L.L.C. | 4.79 | 9,365,463 | +4.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.13 | 8,080,573 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.97 | 7,759,495 | +0.0 | 03/31/2026 |
| Wellington Management Company LLP | 2.72 | 5,308,924 | +113.7 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Blue Owl Credit Income Corp D | 3.90 | 7,616,415 | +79.1 | 03/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.87 | 5,618,758 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer | 749,013 | 49,884,266 $ | Aug 18, 2026 | both |
| Trimarchi Thomas | President and CFO | 336,529 | 22,412,831 $ | Aug 16, 2026 | direct |
| Apuli Maricel | Chief Accounting Officer | 122,687 | 8,170,954 $ | Aug 16, 2026 | direct |
| Ellis Andrea | Director | 22,579 | 1,503,761 $ | Jul 9, 2026 | direct |
| Cook Jennifer E. | Director | 8,383 | 558,308 $ | Jul 9, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 100 | 85.65 | 8,565 |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,800 | 84.69 | 152,436 |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 8,100 | 83.86 | 679,256 |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,199 | 83.77 | 100,444 |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 14,602 | 82.99 | 1,211,852 |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 17,279 | 82.21 | 1,420,514 |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,900 | 81.15 | 154,184 |
| Aug 16, 2026 | Trimarchi Thomas | President and CFO | Other | 22,781 | 79.86 | 1,819,291 |
| Aug 16, 2026 | Kumar Neil | Chief Executive Officer | Other | 36,237 | 79.86 | 2,893,887 |
| Aug 16, 2026 | Kumar Neil | Chief Executive Officer | Other | 6,520 | – | – |
| Aug 16, 2026 | Kumar Neil | Chief Executive Officer | Other | 11,554 | – | – |
| Aug 16, 2026 | Kumar Neil | Chief Executive Officer | Other | 19,599 | – | – |
| Aug 16, 2026 | Kumar Neil | Chief Executive Officer | Other | 33,544 | – | – |
| Aug 16, 2026 | Apuli Maricel | Chief Accounting Officer | Other | 4,714 | 79.86 | 376,460 |
| Jul 30, 2026 | Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | 80.06 | 160,120 |
| Jul 9, 2026 | Ellis Andrea | Director | Sell | 17,167 | 84.00 | 1,442,028 |
| Jul 9, 2026 | Ellis Andrea | Director | Other | 17,167 | 16.75 | 287,547 |
| Jul 9, 2026 | Cook Jennifer E. | Director | Sell | 112,422 | 90.00 | 10,117,980 |
| Jul 9, 2026 | Cook Jennifer E. | Director | Sell | 36,167 | 84.00 | 3,038,028 |
| Jul 9, 2026 | Cook Jennifer E. | Director | Other | 17,167 | 16.75 | 287,547 |
| Jul 9, 2026 | Cook Jennifer E. | Director | Other | 112,422 | 29.00 | 3,260,238 |
| Jul 9, 2026 | Cook Jennifer E. | Director | Other | 19,000 | 8.45 | 160,550 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.